ATE468390T1 - System und verfahren zur produktion von antikörpern in der pflanzenzellkultur - Google Patents

System und verfahren zur produktion von antikörpern in der pflanzenzellkultur

Info

Publication number
ATE468390T1
ATE468390T1 AT05796809T AT05796809T ATE468390T1 AT E468390 T1 ATE468390 T1 AT E468390T1 AT 05796809 T AT05796809 T AT 05796809T AT 05796809 T AT05796809 T AT 05796809T AT E468390 T1 ATE468390 T1 AT E468390T1
Authority
AT
Austria
Prior art keywords
cell culture
plant cell
producing antibodies
antibodies
production
Prior art date
Application number
AT05796809T
Other languages
English (en)
Inventor
Yoseph Shaaltiel
Sharon Hashmueli
Daniel Bartfeld
Gideon Baum
Tal Ratz
Einat Mizrachi
Yehava Forester
Original Assignee
Protalix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protalix Ltd filed Critical Protalix Ltd
Application granted granted Critical
Publication of ATE468390T1 publication Critical patent/ATE468390T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/13—Immunoglobulins specific features characterized by their source of isolation or production isolated from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AT05796809T 2004-10-13 2005-10-11 System und verfahren zur produktion von antikörpern in der pflanzenzellkultur ATE468390T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61764604P 2004-10-13 2004-10-13
PCT/IL2005/001075 WO2006040764A2 (en) 2004-10-13 2005-10-11 System and method for production of antibodies in plant cell culture

Publications (1)

Publication Number Publication Date
ATE468390T1 true ATE468390T1 (de) 2010-06-15

Family

ID=35462268

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05796809T ATE468390T1 (de) 2004-10-13 2005-10-11 System und verfahren zur produktion von antikörpern in der pflanzenzellkultur

Country Status (12)

Country Link
US (1) US8119406B2 (de)
EP (1) EP1799813B1 (de)
JP (1) JP2008515454A (de)
KR (1) KR20070085291A (de)
AT (1) ATE468390T1 (de)
AU (1) AU2005293147A1 (de)
CA (1) CA2583691A1 (de)
DE (1) DE602005021379D1 (de)
IL (1) IL182517A (de)
MX (1) MX2007004414A (de)
WO (1) WO2006040764A2 (de)
ZA (1) ZA200703124B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050032211A1 (en) * 1996-09-26 2005-02-10 Metabogal Ltd. Cell/tissue culturing device, system and method
IL155588A0 (en) * 2003-04-27 2003-11-23 Metabogal Ltd Methods for expression of enzymatically active recombinant lysosomal enzymes in transgenic plant root cells and vectors used thereby
US20100196345A1 (en) * 2003-04-27 2010-08-05 Protalix Production of high mannose proteins in plant culture
US7951557B2 (en) 2003-04-27 2011-05-31 Protalix Ltd. Human lysosomal proteins from plant cell culture
JP2008515454A (ja) 2004-10-13 2008-05-15 プロタリクス リミテッド 植物細胞培養における抗体製造のシステムおよび方法
US8338134B2 (en) 2007-02-09 2012-12-25 Centre National De La Recherche Scientifique - Cnrs Expression of polypeptides from the nuclear genome of Ostreococcus sp
EP2150608B1 (de) * 2007-05-07 2017-11-29 Protalix Ltd. Grossvolumiger einweg-bioreaktor
RU2370280C2 (ru) * 2007-10-08 2009-10-20 Институт физико-химической биологии им. А.Н.Белозерского СПОСОБ СУПЕРПРОДУКЦИИ В РАСТЕНИИ АНТИТЕЛ ПРОТИВ ОНКОГЕНА HER2/neu
JP2012521786A (ja) 2009-03-30 2012-09-20 モウント シナイ スクール オフ メディシネ インフルエンザウイルスワクチン及びその使用
EP2470199B1 (de) 2009-08-28 2019-05-22 Icahn School of Medicine at Mount Sinai Dosiserhöhungs- und enzymersatztherapie zur behandlung mangelnder saurer sphingomyelinase
MX2012011300A (es) 2010-03-30 2012-11-29 Sinai School Medicine Vacunas del virus de influenza y usos de las mismas.
HK1200102A1 (en) 2011-09-20 2015-07-31 西奈山医学院 Influenza virus vaccines and uses thereof
NZ627796A (en) 2012-12-18 2017-07-28 Icahn School Med Mount Sinai Influenza virus vaccines and uses thereof
US9908930B2 (en) 2013-03-14 2018-03-06 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
US10214747B2 (en) 2014-01-09 2019-02-26 Kentucky Bioprocessing, Inc. Method of purifying monoclonal antibodies
GB201411802D0 (en) 2014-07-02 2014-08-13 Univ Bradford Effervescent compositions
US9340604B1 (en) 2014-10-29 2016-05-17 Aridis Pharmaceuticals, Inc. Human monoclonal antibody specific for the F protein of respiratory syncytial virus (RSV)
EP3247389A4 (de) 2015-01-23 2019-10-30 Icahn School of Medicine at Mount Sinai Influenzavirusschutzimpfpläne
MX2018015755A (es) 2016-06-15 2019-08-29 Icahn School Med Mount Sinai Proteinas de hemaglutinina de virus de influenza y usos de las mismas.
EP3550028A4 (de) 2016-11-30 2020-09-02 Kirin Holdings Kabushiki Kaisha Verfahren zur herstellung von nützlichen proteinen mithilfe einer pflanze
CA3058652A1 (en) 2017-04-07 2018-10-11 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
US12364746B2 (en) 2018-06-21 2025-07-22 Icahn School Of Medicine At Mount Sinai Mosaic influenza virus hemagglutinin polypeptides and uses thereof
CA3137160A1 (en) 2019-04-24 2020-10-29 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
CA3169722A1 (en) * 2020-03-02 2021-09-10 Deshui Zhang Enhanced expression yield of immunoglobulin a in eukaryotes
JP7803067B2 (ja) * 2021-02-10 2026-01-21 東ソー株式会社 フコース結合性タンパク質の製造方法
WO2025019631A1 (en) 2023-07-19 2025-01-23 Icahn School Of Medicine At Mount Sinai Immunogenic compositions containing inactivated influenza a virus and cpg oligonucleotide adjuvant and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080560A (en) * 1994-07-25 2000-06-27 Monsanto Company Method for producing antibodies in plant cells
AR020090A1 (es) * 1998-06-15 2002-04-10 John Innes Ct Celula vegetal monocotiledonea o semilla de ella,planta o parte de una planta, metodo para hacer una celula vegetal monocotiledonea, metodo para hacer unaplanta, uso de una construccion de expresion para producir una celula de planta o semilla monocotiledonea, y uso de una construccion de expresion
WO2000011953A1 (en) * 1998-09-01 2000-03-09 Penn State Research Foundation Method and apparatus for aseptic growth or processing of biomass
US6528063B2 (en) * 1999-01-04 2003-03-04 Rahan Meristem Recombinant vaccines against IBDV
US6962700B1 (en) * 2000-09-13 2005-11-08 Atopix Pharmaceuticals Corporation Method of manufacturing immune globulin
CN1533438A (zh) * 2001-06-08 2004-09-29 �����Ŵ��Ƽ���˾ 在植物生产蛋白质的方法
WO2003013598A2 (en) 2001-08-09 2003-02-20 Lam Dominic M K Novel vaccine compositions and methods of vaccine preparation for veterinary and human diseases
CL2003002461A1 (es) 2002-11-27 2005-01-07 Dow Chemical Company Agroscien Inmunoglobulina que comprende al menos un glicano afucosilado, composicion que la contiene, secuencia nucleotidica y vector que la comprende, procedimiento para producir dicha inmunoglobulina en plantas.
ES2269595T3 (es) 2002-12-20 2007-04-01 Greenovation Biotech Gmbh Metodo para producir proteinas glicosiladas heterologas en celulas de briofita.
JP2008515454A (ja) 2004-10-13 2008-05-15 プロタリクス リミテッド 植物細胞培養における抗体製造のシステムおよび方法

Also Published As

Publication number Publication date
DE602005021379D1 (de) 2010-07-01
WO2006040764A2 (en) 2006-04-20
US8119406B2 (en) 2012-02-21
MX2007004414A (es) 2007-09-25
JP2008515454A (ja) 2008-05-15
IL182517A (en) 2012-06-28
AU2005293147A1 (en) 2006-04-20
WO2006040764A3 (en) 2006-07-06
IL182517A0 (en) 2007-09-20
KR20070085291A (ko) 2007-08-27
CA2583691A1 (en) 2006-04-20
EP1799813A2 (de) 2007-06-27
EP1799813B1 (de) 2010-05-19
US20090082548A1 (en) 2009-03-26
ZA200703124B (en) 2008-08-27

Similar Documents

Publication Publication Date Title
DE602005021379D1 (de) System und verfahren zur produktion von antikörpern in der pflanzenzellkultur
DE602004025805D1 (de) Verfahren zur herstellung von antikörpern
NO20072719L (no) Serumfritt cellekulturmedium for pattedyrceller
ATE474910T1 (de) L-glutaminsäure produzierender mikroorganismus sowie verfahren zur produktion von l- glutaminsäure
DK1428878T3 (da) Fremgangsmåde til produktion og oprensning af erythropoietin
EA202090067A2 (ru) Способ получения рекомбинантного adamts13 в культуре клеток
NZ595786A (en) Placental stem cell populations
SG10201408300PA (en) Processing of amplified dna fragments for sequencing
MX2008014692A (es) Metodo de cultivo para obtener una poblacion clonal de celulas b especificas de antigeno.
ATE511751T1 (de) Verfahren für die produktion von milben
SG10201803982TA (en) Antibodies and processes for preparing the same
WO2008024769A3 (en) Intensified perfusion production method
ATE521695T1 (de) Zirkuläres dna-molekül mit einem konditionalen replikationsursprung, verfahren zur herstellung davon und ihre verwendung in der gentherapie
EA200800996A1 (ru) Способ получения т-клеточной популяции
PL439807A1 (pl) Sposoby oczyszczania przeciwciał i ich kompozycje
WO2007130543A3 (en) Method for producing stable mammalian cell lines producing high levels of recombinant proteins
DE602005002829D1 (de) Verwendung eines serumfreien zellkulturmediums zur produktion von il-18bp in säugerzellen
ATE468398T1 (de) Herstellungsverfahren zur produktion aktiver und löslicher proteine in prokaryonten und polycistronische vektoren dafür
GB0208041D0 (en) Method of culturing animal cells
ATE469917T2 (de) Verfahren zur gewinnung von antikörpern
GB0808244D0 (en) Reprogramming and genetic modification of cells
ATE505535T1 (de) Verfahren zur herstellung stabiler b-lymphozyten
DE602006010934D1 (de) Verfahren zur Identifizierung von Epitopen in Zusammenhang mit Immunogenität bei Biopharmazeutika
DE69934250D1 (de) Zusammensetzungen und verfahren zur herstellung monoklonaler antikörper, repräsentativ für einen spezifischen zelltyp
ATE501272T1 (de) Verfahren zur produktion von pflanzen mit verbesserter transpirationseffizienz sowie davon produzierte pflanzen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties